Hyperprogression, defined as a rapid acceleration of tumor growth, is a new aggressive pattern reported in a fraction of lung cancer, melanoma, renal carcinoma [39] and head and neck carcinoma [40] cases treated with anti-PD-1/PD-L1. The gene discussed is CD274; the disease is neoplasm.